Smith & Nephew plc (SN.L)
| Previous close | 985.60 |
| Open | 985.00 |
| Bid | 680.00 x 0 |
| Ask | 1,025.00 x 0 |
| Day's range | 983.00 - 1,006.00 |
| 52-week range | 887.00 - 1,315.00 |
| Volume | |
| Avg. volume | 3,724,889 |
| Market cap | 8.715B |
| Beta (5Y monthly) | 0.51 |
| PE ratio (TTM) | 41.53 |
| EPS (TTM) | 0.24 |
| Earnings date | 01 Aug 2024 |
| Forward dividend & yield | 0.30 (3.07%) |
| Ex-dividend date | 28 Mar 2024 |
| 1y target est | 12.94 |
Simply Wall St.With 83% ownership of the shares, Smith & Nephew plc (LON:SN.) is heavily dominated by institutional owners
Key Insights Given the large stake in the stock by institutions, Smith & Nephew's stock price might be vulnerable to...
GlobeNewswireSmith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
Smith+Nephew (NYSE:SNN; LSE:SN), the global medical technology company is pleased to announce exciting data for its ALLEVYN LIFE Dressing in a recent study by Professor Amit Gefen and his research group published in the International Wound Journal,1 that shows a novel mechanism of action relating to pressure injury prevention (PIP). The study found that due to the independent and non-bonded internal layers of ALLEVYN LIFE Dressing, a layer-on-layer sliding phenomenon occurs and allows for dissip
- GlobeNewswire
Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia
Compact, single-use, and simple-to-use technology offers surgeons a fast, reliable navigation solution for hip arthroplasty Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announced an agreement with NAVBIT to exclusively distribute the NAVBIT SPRINT™ in Australia during the recent Australian Orthopedics Association COE Meeting in Sydney. A single-use, sterile navigation system with everything provided in a small carton, NAVBIT SPRINT™ is designed to suit busy surgeons -
